University of Pittsburgh Secures $1m NIH Grant for Collaboration with Tiba Biotech Developing RNA-based COVID-19 Vaccine

Researchers at the University of Pittsburgh (Pitt) now pursue three COVID-19 vaccines, including 1) the PittCoVac announced by TrialSite News on April 3; 2) the investigational vaccine out of Pitt’s Center for Vaccine Research in collaboration with Austrian biotech...

MIT-based Spinoff Sigilon Therapeutics Raises $80.3m Series B to Advance “Shielded Living Therapeutics” to Clinical Trials

Sigilon Therapeutics, Inc., a biotechnology company developing cures for patients with chronic diseases through its Shielded Living Therapeutics Platform, announced it completed a $80.3 million Series B financing. This money will be put to use supporting the...

Pin It on Pinterest